Comparison of indium-111 antimyosin antibody and technetium-99m pyrophosphate localization in reperfused and nonreperfused myocardial infarction

Kan Takeda, Norman D. LaFrance, Harlan F. Weisman, Henry N. Wagner, Lewis C. Becker

Research output: Contribution to journalArticlepeer-review

11 Scopus citations


Recent imaging studies suggest that technetium-99m (Tc-99m) pyrophosphate yields a considerably larger estimate of myocardial infarct size than does indium-111 (In-111) monoclonal antimyosin antibody. To determine whether Tc-99m pyrophosphate may be taken up by reversibly injured myocytes, particularly in the setting of coronary reperfusion, the tissue localization of Tc-99m pyrophosphate and antimyosin antibody was compared in 11 dogs 24 to 68 h after anterior descending coronary artery occlusion (4 dogs with permanent occlusion, 7 with reperfusion). Technetium-99m pyrophosphate and In-111 antimyosin antibody content was determined in serial 2 to 3 mm wide endocardial and epicardial samples taken through the infarct zone in multiple short-axis left ventricular slices. The number of samples with increased In-111 antimyosin antibody (defined as ≧ mean + 2 SD of normal) was not significantly different from that with increased Tc-99m pyrophosphate. This was true in both reperfused and nonreperfused infarcts. However, the intensity of uptake of Tc-99m pyrophosphate exceeded that of In-111 antimyosin antibody, particularly in the border zones of reperfused infarcts, and the area with moderate to marked increase in tracer uptake (≥2 times normal) was significantly larger with Tc-99m pyrophosphate than In-111 antimyosin antibody (p < 0.001). A specific zone of abnormal Tc-99m pyrophosphate with normal In-111 antimyosin antibody content could not be identified. Histologic evidence of myocardial necrosis was found in virtually every sample with increased In-111 antimyosin antibody, Tc-99m pyrophosphate, or both. Thus, the spatial extent of In-111 antimyosin antibody and Tc-99m pyrophosphate uptake was identical in myocardial infarction as measured by ex vivo tissue counting. Larger scintigraphic estimates of infarct size with Tc-99m pyrophosphate are probably due to more intense uptake of Tc-99m pyrophosphate in necrotic myocytes, particularly those located at the infarct boundary, rather than uptake in injured viable tissue.

Original languageEnglish (US)
Pages (from-to)519-526
Number of pages8
JournalJournal of the American College of Cardiology
Issue number2
StatePublished - 1991
Externally publishedYes

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Comparison of indium-111 antimyosin antibody and technetium-99m pyrophosphate localization in reperfused and nonreperfused myocardial infarction'. Together they form a unique fingerprint.

Cite this